Corporate merger & acquisition (“M&A”) is a major practice area of Tian Yuan. We've provided legal support to clients in numerous domestic and international M&A projects, including overseas reverse takeover projects. Our clients active in the M&A area include major state-owned corporations, foreign investors, financial institutions, real estate developers, high-tech companies, education institutions and entities, construction companies, pharmaceutical companies, mining companies, and chemical companies. 

Tian Yuan attorneys closely follow the development of M&A laws in China, specifically laws and regulations on industry regulation, state-owned assets administration, foreign exchange, taxation, intellectual property, and securities regulation.

Awards & Rankings

• Recommended firm in Corporate/M&A, Chambers

• Recommended firm in Corporate/M&A, Legal 500

• Recommended firm in Corporate/M&A, IFLR1000

• Top-tier firm in Corporate/M&A, LEGALBAND

• TOP 10 Intermediary Service for M&A of Listed Companies, ChinaVenture

• Top 10 M&A Firms, IBMAWANG Annual Rankings

• TOP 10 M&A Firms in China, China Business Law Journal

• Dalian Wanda Commercial's privatization --- M&A Deal of the Year, China Law & Practice 2017

Comments from Media

Chambers 2018 :“This team constantly attracts work from SOE clients in relation to the full spectrum of capital markets transactions. Demonstrates a good track record in handling domestic issuances and is active in relation to red-chip spin-off and IPO matters. Peers are impressed by the volume of both the firm’s domestic and overseas capital markets work.”

The range of services include:

• Education

• Healthcare

• TMT

• PE/VC

• Real estate & construction

• Infrastructure & project finance (PPP)

• Cross-Border investment/M&A & The Belt and Road
  

Notable Represented Clients

• Bright Food

• China Mobile

• Lenovo

• Founder Group

• China Telecom

• Haier Group

• China Resources

• Air China

• Beijing Capital Agribusiness Group

• BTG

• Aluminum Corporation of China

• Wilmar International Limited

• Beijing State-Owned Capital Operation and Management Center

• Sinochem

• Sinopharm